Original language | English |
---|---|
Pages (from-to) | 408-411 |
Number of pages | 4 |
Journal | Obstetrical and Gynecological Survey |
Volume | 47 |
Issue number | 6 |
DOIs |
|
Publication status | Published - 1 Jun 1992 |
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 Randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Part II
Early Breast Cancer Trialists' Collaborative Group
- Diabetes Research Laboratories, Radcliffe Infirmary
- AGETBC
- Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust
- IKNL
- BMFT
- Ruprecht-Karls Universitat Heidelberg - University of Heidelberg
- Sächsische Akademie der Wissenschaften
- Birmingham General Hospital
- Fondation Bergomé
- Dana-Farber Cancer Institute
- British Columbia Cancer Agency Branch
- Cancer Institute Hospital of JFCR
- Cancer Research UK Cambridge Institute
- Centre François Baclesse
Research output: Contribution to journal › Commentary/debate › peer-review